Skip to main content
OpenTrials
Completed

NCT Number: NCT02725801

Comparison of One-port and Two-port Tissue Expanders for Breast Reconstruction

Appropriate patients undergoing going immediate breast reconstruction with tissue expanders following mastectomy will be randomized to receive one-port or two-ports tissue expanders. Their clinical course, complications, and outcome will be analyzed.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year and older

Sex eligibility

Female

Study type

Interventional

Phase

Not applicable

Primary location

University of Kentucky

Lexington, Kentucky, 40536, United States

About this study

The goal of this study is to compare a traditional single port expander with a two-port expander for equivalency when used for breast reconstruction following mastectomy. Complication rates that will be tracked include seroma, mastectomy skin flap necrosis, infection, wound dehiscence, need for explantation of the expander. Management of seromas will be compared between the two groups. The investigators hypothesize that the AlloX2 expander will be as effective in achieving the final outcome of completion of the second stage of reconstruction with equal or improved complication rates.

Study Design A prospective 1:1 randomized, single center, open label study will compare the traditional 1- port tissue expander with the AlloX2 2-port expander placed during immediate tissue expander breast reconstruction. Due to the nature of the surgery, the study cannot be blinded. Patients will be followed until completion of expansion and exchange for the permanent implant which typically takes 2 to 3 months. Risks factors that have been previously identified to be associated with increased postoperative complications include smoking, obesity, breast size, diabetes, radiation therapy, and expander fill volume will be identified. The final outcome is completion of expansion and exchange to permanent implant.

Standard operative procedure and postoperative care will be done. Both groups will have the same two external drains placed which is standard operative procedure. Complications will be noted at each postoperative clinic visit and entered into a database. Complication rates will be compared between the two groups and associations with risk factors will be analyzed. There will be no cross-over into the other group in case of reconstructive failure. Treatment failures will be treated in the same fashion in the two groups.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • patient agrees to immediate tissue expander breast reconstruction
  • a suitable patient for tissue expander reconstruction

Exclusion criteria

  • not a surgical candidate for immediate breast reconstruction
  • age less than 18
  • patient declines tissue expander reconstruction
  • patient anticipated to need radiation therapy postoperatively

Treatment and study plan

Allergen one-port tissue expander placement

Device

patients will be randomized to receive a one port or two port tissue expander for breast reconstruction

Other names: Allergen one-port tissue expander

AlloX2 two-port tissue expander placement

Device

patients will be randomized to receive a one port or two port tissue expander for breast reconstruction

Other names: AlloX2 two-port tissue expander

Primary outcomes

  1. Number of Participants With Successful Replacement of Tissue Expander With Permanent Implant

    Time frame: 3 months

    The number of patients that are able to undergo replacement of the tissue expander between the two arms will be compared

Secondary outcomes

  1. Number of Participants Who Required Additional Intervention

    Time frame: 3 months

    Number of participants requiring additional intervention following tissue expander placement will be compared between the two arms of the study

Sponsors and collaborators

Lead sponsor

Lesley Wong

Other

Registry information

Official study title

Randomized Clinical Trial Comparing 1-Port and 2-Port Tissue Expanders for Breast Reconstruction

Important dates

Study start
2016
Primary completion
2019
Study completion
2020
First posted
Apr 1, 2016
Registry last updated
Sep 4, 2020

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.